magrolimab
gilead
['magrolimab']
#magrolimab is an investigational mab against cd47 &amp; macrophage checkpoint inhibitor that is designed to interfere with recognition of cd47 by sirp receptor on macrophages, thus blocking the "don't eat me" signal used by cancer cells to avoid being ingested by macrophages #ash22 
Director Pediatric Hematology Oncology & Bone Marrow Transplant, Medanta The Medicity . RT are not endorsement and views are my own